MHK vs SYRE · P/E 15, rev $5.72B vs $7.60B cap
Mohawk Industries Inc (MHK) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
Mohawk Industries Inc (MHK) is a furnishings, fixtures & appliances company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported MHK revenue for 2026-07-04 was $5.72B. Net income was $313.2M. MHK currently screens at market cap $7.12B and trailing P/E 14.9.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
MHK currently screens at market cap $7.12B and trailing P/E 14.9. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the MHK and SYRE stock pages for the full models.
Not investment advice.